Quarterly report pursuant to Section 13 or 15(d)

NON CONTROLLING INTEREST (Details)

v3.20.2
NON CONTROLLING INTEREST (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Net loss attributable to the non-controlling interest     $ (14,668) $ (1,455)
BioCorRx Pharmaceuticals, Inc [Member]        
Net loss $ (12,572) $ (5,900) $ (60,611) $ (6,014)
Average Non-controlling interest percentage of profit/losses 24.20% 24.20% 24.20% 24.20%
Net loss attributable to the non-controlling interest $ (3,042) $ (1,427) $ (14,668) $ (1,455)